Alberta confirms blood clot disorder death linked to AstraZeneca vaccine
EDMONTON — An Alberta woman in her 50s has died from a rare blood clot disorder after receiving the Oxford-AstraZeneca COVID-19 vaccine.
The province’s chief medical officer of health confirmed in a statement the death linked to vaccine-induced immune thrombotic thrombocytopenia or VITT.
Dr. Deena Hinshaw says the fatality is the second VITT case and only death related to VITT out of more than 253,000 doses of AstraZeneca that have been administered in Alberta to date.
Hinshaw says while any death is tragic, “it is important to remember that the risks of dying or suffering other severe outcomes from COVID-19 remain far greater than the risk following AstraZeneca vaccine.”
More on: lethbridgenewsnow.com